CompletedPHASE1, PHASE2NCT04764422

Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Mahidol University
Principal Investigator
Punnee Pitisutthithum
Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University
Intervention
Normal Saline(biological)
Enrollment
455 target
Eligibility
18-75 years · All sexes
Timeline
20212022

Study locations (1)

Collaborators

The Government Pharmaceutical Organization

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04764422 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome

← Back to all trials